Neurolixis
Get Full AccessDescription
- Neurolixis Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of human central nervous system diseases including Parkinson's disease, Rett syndrome, depression and schizophrenia.Neurolixis advances the clinical development of in-licensed drugs as well as identifying novel chemical entities. Neurolixis actively pursues collaborations and has been awarded grants by the Michael J. Fox Foundation, the International Rett Syndrome Foundation and the Rett Syndrome Research Trust.
-
Headquarters:251 Little Falls Drive , Wilmington, Delaware, United States
More -
Phone Number: +1 949-975-9833
-
Website: https://www.neurolixis.com
-
Employees:5
-
Revenue:$1 - 10M
-
Legal Name:Neurolixis
-
Neurolixis's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Neurolixis
-
Where are Neurolixis's Headquarters?
Neurolixis's Headquarters are in 251 Little Falls Drive ,Wilmington,Delaware,United States
-
What is Neurolixis's phone number?
Neurolixis's phone number is +1 949-975-9833
-
What is Neurolixis's official website?
Neurolixis's official website is https://www.neurolixis.com
-
What is Neurolixis's Revenue?
Neurolixis's revenue is $1 - 10M
-
What is Neurolixis's NAICS code?
Neurolixis's NAICS code is 541713
-
How many employees are working in Neurolixis
Neurolixis has 5 employees
-
What is Neurolixis's Industry?
Neurolixis is in the industry of Pharmaceuticals
-
Who is Neurolixis's Chief Operations Officer?
Neurolixis's Chief Operations Officer is Mark Kleven